Skip to Content


Good Guidance Practices; Technical Amendment

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Food and Drug Administration, HHS.


Final rule; technical amendment.


The Food and Drug Administration (FDA or Agency) is amending its good guidance practices regulation to inform the public on how to electronically submit a draft of a proposed guidance to the Agency. This technical amendment is nonsubstantive.


This rule is effective March 29, 2018.

Start Further Info


Megan Velez, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 4254, Silver Spring, MD 20993-0002, 301-796-9301.

End Further Info End Preamble Start Supplemental Information


FDA is amending 21 CFR 10.115(f)(3), good guidance regulations, by adding language on how the public can electronically submit drafts of proposed guidance documents to participate in the development and issuance of guidance documents. The amendment provides an option for submitting the draft of a proposed guidance to the Agency electronically through at Docket No. FDA-2013-S-0610.

Publication of this document constitutes final action on the change under the Administrative Procedure Act (5 U.S.C. 553). This technical amendment is nonsubstantive. FDA therefore, for good cause, has determined that notice and public comment are unnecessary under 5 U.S.C. 553(b)(3)(B). Further, this rule places no burden on affected parties for which such parties would need a reasonable time to prepare for the effective date of the rule. Accordingly, FDA, for good cause, has determined Start Printed Page 13416this technical amendment to be exempt under 5 U.S.C. 553(d)(3) and that the rule can become effective upon publication.

Start List of Subjects

List of Subjects in 21 CFR Part 10

  • Administrative practice and procedure
  • News media
End List of Subjects

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 10 is amended as follows:

Start Part


End Part Start Amendment Part

1. The authority citation for part 10 continues to read as follows:

End Amendment Part Start Authority

Authority: 5 U.S.C. 551-558, 701-706; 15 U.S.C. 1451-1461; 21 U.S.C. 141-149, 321-397, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 U.S.C. 201, 262, 263b, 264.

End Authority Start Amendment Part

2. In § 10.115, add two sentences to the end of paragraph (f)(3) to read as follows:

End Amendment Part
Good guidance practices.
* * * * *

(f) * * *

(3) * * * If you wish to submit the draft of a proposed guidance document electronically, submit it through at Docket No. FDA-2013-S-0610. It is only necessary to submit one copy.

* * * * *
Start Signature

Dated: March 20, 2018.

Leslie Kux,

Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2018-06252 Filed 3-28-18; 8:45 am]